2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
Wed 20 Mar
|Seaport Hotel, Boston, MA
Leveraging Technology, Safeguarding IP, and Securing Funding to Accelerate Development in RNA, Gene Editing Tech and Regenerative Medicines.
Time & Location
20 Mar 2024, 07:00 – 21 Mar 2024, 19:00
Seaport Hotel, Boston, MA, 1 Seaport Ln, Boston, MA 02210, USA
About the event
Hosted by American Conference Institute, the 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities returns for another exciting year with curated programming that will highlight leveraging technology, safeguarding IP, and securing funding to accelerate development in the RNA, gene editing tech and regenerative medicines.
This year’s conference co-chairs include Cristin Berkey (Senior Director, IP and Contracts Counsel, Abata Therapeutics), Forrester Liddle (Head of IP and Legal for US, Novo Nordisk), and Adrian Looney (Chief Intellectual Property Counsel, Vertex Pharmaceuticals).
Over the course of two days, therapeutic pioneers, innovators, investors, executives, and legal experts will converge to evaluate and shape the future of current and emerging modalities such as RNA, Gene Editing Tech, and Regenerative Modalities.
The Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies takes place on March 20-21, 2024, at the Seaport Hotel, in…